News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Vibalogics has announced it is expanding its global footprint with a late phase clinical and commercial manufacturing facility near Boston, Massachusetts, a major milestone as it looks to advance its services to drug developers across the globe.
The European Medicines Agency (EMA) has started a rolling review of Moderna’s mRNA COVID-19 vaccine candidate.
The future of treatment for many of the most challenging diseases in the world is said to reside in personalized cell and gene therapy (CGT). These expensive and complex therapies have proven highly effective in multiple cases, but a challenge remains...
A leader from the clinical services provider shares insights gained from comparing two COVID-19 vaccine trials, and tales told by the differences.
The European Commission has reached an agreement with CureVac for up to 405 million doses of its mRNA-based COVID-19 vaccine candidate: representing the biggest COVID-19 vaccine deal the Commission has inked so far.